PMID: 7543893Aug 30, 1995Paper

Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update

International Journal of Radiation Oncology, Biology, Physics
M S AnscherR Prosnitz

Abstract

To determine the role of adjuvant postoperative radiotherapy (RT) following radical prostatectomy (RP) in a group of patients with pathologic Stage T3/4 adenocarcinoma of the prostate followed for a median of 10 years after treatment. Between 1970 and 1983, 159 patients underwent RP for newly diagnosed adenocarcinoma of the prostate and were found to have pathologic Stage T3/4. Forty-six received adjuvant RT and 113 did not. Radiotherapy usually consisted of 45-50 Gy to the whole pelvis followed by a boost to the prostate bed of 10-15 Gy, to a total dose of 55-65 Gy. Patients were analyzed with respect to survival, disease-free survival, local control, and freedom from distant metastases. A rising prostate-specific antigen in the absence of other evidence of relapse was scored as a separate category of recurrence. Both groups of patients have been followed for a median of 10 years. The actuarial survival at 10 and 15 years was 62% and 62% for the RT group compared to 52% and 37%, respectively, for the RP group (p = 0.18). The disease-free survival for the Rt group was 55% and 48% at 10 and 15 years, respectively, compared to 37% and 33% for the RP group (p = 0.16). Similarly, there was no difference in the rate of distant metas...Continue Reading

References

Sep 1, 1991·International Journal of Radiation Oncology, Biology, Physics·Z PetrovichD G Skinner
Jun 1, 1989·International Journal of Radiation Oncology, Biology, Physics·B E ShevlinR M Shetty
Jul 1, 1987·International Journal of Radiation Oncology, Biology, Physics·G M JacobsonJ R Stewart
Feb 1, 1986·International Journal of Radiation Oncology, Biology, Physics·J D FormanS E Order
Oct 1, 1984·International Journal of Radiation Oncology, Biology, Physics·M V PilepichR J Baglan

❮ Previous
Next ❯

Citations

Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·S E Schild
Mar 17, 2007·World Journal of Urology·Dirk Bottke, Thomas Wiegel
May 15, 1995·International Journal of Radiation Oncology, Biology, Physics·J J WuM S Anscher
Feb 1, 1996·International Journal of Radiation Oncology, Biology, Physics·M S Anscher
Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Carlos VargasAlvaro A Martinez
May 7, 2002·Urology·Ramona MayerArnulf Hackl
Feb 23, 1999·The Urologic Clinics of North America·D K OrnsteinG L Andriole
Oct 10, 2001·The Urologic Clinics of North America·S E Schild, T M Pisansky
Apr 11, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C CattonM Milosevic
Aug 19, 2000·International Journal of Radiation Oncology, Biology, Physics·S Parikh, D Nori
Jun 14, 2002·International Journal of Radiation Oncology, Biology, Physics·Zbigniew PetrovichDonald G Skinner
Oct 16, 2002·International Journal of Radiation Oncology, Biology, Physics·Larry KestinAlvaro Martinez
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·John A KalapurakalRamananda M Shetty
Oct 6, 1997·International Journal of Radiation Oncology, Biology, Physics·M J ZelefskyS A Leibel
Jul 1, 1997·International Journal of Radiation Oncology, Biology, Physics·M M MorrisW U Shipley
Jul 4, 1998·International Journal of Radiation Oncology, Biology, Physics·S M EulauS L Hancock
Sep 7, 1999·International Journal of Radiation Oncology, Biology, Physics·R K ValicentiC J Newschaffer
Jun 18, 2003·Urologic Oncology·Eila C Skinner, L Michael Glode
Jun 9, 2004·International Journal of Radiation Oncology, Biology, Physics·Cesare CozzariniEugenio Villa
Dec 1, 2009·Urologic Oncology·Jonathan C PicardThomas E Keane
Oct 13, 2007·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·M BollaUNKNOWN au nom des groupes génito-urinaire et radiothérapie de l'EORTC
Jun 15, 2011·Nature Reviews. Urology·Amit R Patel, Andrew J Stephenson
Sep 22, 2010·Korean journal of urology·Dalsan YouChoung-Soo Kim
Apr 5, 2007·Urologia Internationalis·Dirk Bottke, Thomas Wiegel
Mar 11, 2003·Prostate Cancer and Prostatic Diseases·S R J Bott, R S Kirby
Apr 9, 2009·Scandinavian Journal of Urology and Nephrology·Sonny SchelinGunnar Aus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
S E SchildR G Ferrigni
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
T WiegelU M Carl
© 2021 Meta ULC. All rights reserved